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Edited by Sandro SonninoAbstract We provide evidence that matrix metalloproteinase-7
(MMP-7) interacts with anionic, cationic and neutral lipid mem-
branes, although it interacts strongest with anionic membranes.
While the catalytic activity of the enzyme remains unaﬀected
upon binding to neutral and negatively charged membranes, it
is drastically impaired upon binding to the positively charged
membranes. The structural data reveal that the origin of these
features lies in the ‘‘bipolar’’ distribution of the electrostatic sur-
face potentials on the crystallographic structure of MMP-7.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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spectroscopy1. Introduction
Due to their involvement in a variety of human diseases,
matrix metalloproteinases (MMPs) have emerged as highly
desirable targets for drug design [1,2]. In physiological milieu,
the degradation of extracellular matrix (ECM) as well as other
selective proteins is accomplished by a coordinated interplay of
24 diﬀerent MMPs [3,4] of which MMP-7 (Matrilysin-1) is
structurally the simplest and among the smallest enzyme [5].
MMP-7 is predominantly expressed in epithelial cells, cleaving
a variety of cell-associated proteins, such as E-cadherin, TNF-
a, Fas ligand, insulin-like growth factors, among others [6,7].
Since some of these non-ECM substrates are conﬁned to the
cell membrane, it would make physiological sense if MMP-7
is recruited to the cell surface to hydrolyze its cognate protein
substrates. In fact, preliminary data from other laboratories
led to the suggestion that MMP-7 interacted with negativelyAbbreviations: MMP-7, matrix metalloproteinase-7; POPC, 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phosphocholine; dansyl-PE, 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N (5-dimethylamino-1-naphthalenes-
ulfonyl) lipid; POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-ser-
ine; PIP2, 1,2-dioleoyl-sn-glycero-3-phosphoinositol-4,5-bisposphate;
CS, cholesterol 3-sulfate; EPOPC; 1-palmitoyl-2-oleoyl-sn-glycero-3-
ethylphosphocholine
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doi:10.1016/j.febslet.2007.11.042charged lipid membranes [8,9]. This appeared surprising since
most MMPs (except for the membrane bound forms) are re-
garded as soluble proteins that ﬁnd their cognate targets via
randomly diﬀusing through the extracellular matrix.
On consideration that the catalytic and regulatory features
of MMP-7 would be ﬁne tuned if it were to be localized on
the plasma membrane, we purported to investigate its potential
interaction with model biological membranes, and discern the
functional consequences of such interactions. As will be de-
tailed in the following sections, MMP-7 indeed interacts with
diﬀerently charged biological membranes albeit its aﬃnity is
more pronounced when the membrane is constituted of nega-
tively charged lipids. The most interesting feature of this
investigation is that whereas the negatively charged (or neu-
tral) membranes do not impair the catalytic activity of the en-
zyme, the positively charged membranes are drastically
inhibitory.2. Materials and methods
2.1. Buﬀers
Composition of buﬀers used for the diﬀerent experiments is de-
scribed in the Electronic Supplementary Information (ESI).
2.2. Cloning, expression, and puriﬁcation of recombinant human MMP-7
The enzyme was cloned, expressed in Escherichia coli BL21 (DE3)
cells and puriﬁed as described by Kannan et al. [10] with slight modi-
ﬁcations as detailed in the ESI.
2.3. Liposome preparation
Large unilamellar vesicles (LUVs) containing diﬀerently charged lip-
ids were prepared by hydration, sonication, and extrusion of thin ﬁlms,
formed by mixing appropriate amounts of chloroformic solutions of
desired lipids as previously described [11].
2.4. Determination of MMP-7–liposome interaction via ﬂuorescence
spectroscopy
The binding of MMP-7 to diﬀerently charged liposomes was deter-
mined by measuring the decrease in the protein’s intrinsic ﬂuorescence
(kex = 283 nm, kem = 343 nm) and the concurrent increase in the
ﬂuorescence of the lipid probe as a function of increasing lipid concen-
tration. 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N (5-dimeth-
ylamino-1-naphthalenesulfonyl) lipid (dansyl-PE) (kem = 526 nm,
Avanti Polar Lipids, Alabaster, AL) was utilized as the liposome
incorporated ﬂuorescence reporter group [12]. All ﬂuorescence
measurements were performed using a LS-50B Perkin–Elmer spec-
troﬂourimeter. The emission spectra were corrected for the back-
ground ﬂuorescence due to increasing dansyl-PE concentration by
performing blank titrations of dansyl-PE-containing liposomes into
buﬀer.blished by Elsevier B.V. All rights reserved.
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The eﬀect of liposomes on MMP-7 activity was determined by mea-
suring the initial rate of the MMP-7 catalyzed reaction using ﬂuoro-
genic peptide (obtained from Calbiochem, CA) of the following
composition: MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 (where
MCA and Dpa stands for (7-Methoxycoumarin-4-yl)acetyl and N-3-
(2,4-dinitrophenyl)-L-2,3-diaminopropionyl, respectively) while main-
taining the excitation and emission wavelengths of 335 nm and
395 nm, respectively. The time course of the reaction was monitored
for about 5 min. MMP-7 in reaction mixture was maintained at
1 lM while the liposome concentration (total lipid) varied between 0
and 250 lM.3. Results and discussion
To probe whether MMP-7 exclusively interacts with the
negatively charged membranes [8,9], or it also interacts with
neutral and positively charged membranes, we performed
binding studies of the enzyme to diﬀerently charged liposomes
as the model membrane system Initially, we observed that
MMP-7 strongly interacts with negatively charged liposomes
containing 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine
(POPS). This appeared feasible in the light of the electrostatic
potentials on the surface of MMP-7 (Fig. 1). Whereas the sur-
face around the active site pocket has negative potential, the
distal (opposite) end of the enzyme surface is predominantly
positive. Given such a ‘‘bipolar’’ distribution of relative charge
density on the protein surface, it appeared likely that MMP-7
would interact with both negative and positively charged lipid
membranes, and the latter interaction would inhibit the en-
zyme activity.
To test the above hypotheses, we determined the inﬂuence of
liposomes bearing diﬀerent charges on the catalytic activity of
MMP-7. We prepared liposomes with zwitterionic 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) as a major
(75–95%) component, and other lipids (contributing diﬀerentFig. 1. Cartoon showing the electrostatic potentials on the surface
MMP-7 (pdb1MMQ) containing bound hydroxamate inhibitor, and
putative binding surfaces for anionic and cationic lipid membranes.
The structural coordinates of MMP-7 were downloaded from the
Research Collaboratory for Structural Bioinformatics (RCSB) Protein
Data Bank (PDB). The red (1.9 kcal/mol) and blue (9.8 kcal/mol)
colors represent the negative and positive potentials, respectively,
calculated via the aid of the GRASP software on a SGI molecular
modeling workstation [14–16].net charges) as minor components. For formulating negatively
charged liposomes, we utilized anionic lipids; POPS, cholesterol
3-sulfate (CS) and 1,2-dioleoyl-sn-glycero-3-phosphoinositol-
4,5-bisposphate (PIP2), which harbour 1, 1, and 3 net
charges, respectively, in their head groups at neutral pH. For
positively charged liposomes, we utilized cationic lipid; 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-ethylphosphocholine (EPOPC),
containing +1 net charge on its head group at neutral pH (for
structures of these lipids, see Fig. S2 of ESI).
The binding of MMP-7 to liposomes was quantiﬁed by mon-
itoring the ﬂuorescence signals of the liposome-dansyl probe as
well as that of the enzyme’s tryptophan/tyrosine residues
(Fig. 2). Note the systematic decrease in the enzyme’s ﬂuores-
cence emission intensity (kem = 343 nm) with concomitant in-
crease in the intensity of the dansyl peak (at 526 nm). The
overall spectral changes conform to a single isosbestic point
at 397 nm, consistent with the ﬂuorescence resonance energy
transfer (FRET) from the excited state of the enzyme’s trypto-
phan/tyrosine residues to the liposome-resident dansyl probe,
and its origin must lie in the formation of the enzyme-liposome
complex [12]. In addition, the dissociation constants calculated
from the liposome concentration-dependent changes in the
ﬂuorescence intensities at 343 nm (due to quenching of the en-
zyme’s ﬂuorescence) and at 526 nm (due to enhancement of the
dansyl ﬂuorescence) were found to be remarkably similar, e.g.,
0.73 lM and 0.87 lM, respectively. In case of cationic lipo-
somes, we observed, however, that whereas the intrinsic ﬂuo-
rescence of MMP-7 was quenched (upon titration with the
liposome), there as no signiﬁcant increase in the dansyl peak
at 526 nm (see Fig. S1 in ESI). This was presumably due to
the absence of energy transfer (due to ‘‘distance’’ or ‘‘orienta-
tion’’ factor) from the enzyme’s tryptophan/tyrosine residues
to the liposome resident dansyl-PE probe (see Fig. 1). Hence,350 400 450 500 550
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Fig. 2. Fluorescence emission spectra during the course of titration of
MMP-7 by anionic liposomes. MMP-7 (1 lM) was titrated with
increasing concentrations of liposomes (containing POPC:POPS:dan-
syl-PE as 65:25:10 mol%), and the emission spectra (kex = 283 nm)
were from 320 nm to 550 nm. The titration data reveals that whereas
the intrinsic ﬂuorescence of MMP-7 is quenched (kem = 343 nm), the
ﬂuorescence intensity of the liposome resident dansyl-PE probe
(kem = 526 nm; due to energy transfer from the protein) is increased.
The inset shows the binding isotherms of liposome–MMP-7 complex,
derived from the ﬂuorescence intensity changes at 343 nm (squares)
and 526 nm (circles), respectively. The solid smooth lines are the best
ﬁt of the data for the Kd values 0.73 ± 0.07 lM (343 nm peak) and
0.87 ± 0.06 lM (526 nm peak), respectively.
Table 1
Kd values of the liposome–MMP-7 complexes
Type of liposomes Kd (lM)
POPC 13.0 ± 1.4
POPS 0.73 ± 0.06
PIP2 0.05 ± 0.01
CS 0.03 ± 0.01
EPOPC 5.0 ± 0.9
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mined by measuring the intrinsic ﬂuorescence of the enzyme
at 343 nm.
To probe the generality of the above ﬁndings, we determined
the binding aﬃnities of MMP-7 with liposomes containing
other negatively charged lipids and with cationic and neutral
liposomes. As is evident from Table 1, the negatively charged
liposomes exhibit the highest binding aﬃnity for MMP-7, and
there is not much diﬀerence in the binding aﬃnity when PIP2
or CS is substituted as the negatively charged lipid. On the
other hand, the binding of MMP-7 to neutral (POPC) and pos-
itively charged (EPOPC) liposomes is relatively weak. Irrespec-
tively, the data of Table 1 clearly show that MMP-7 interacts
with all (diﬀerently charged) liposomes. This was not surpris-
ing in light clustered positive and negative charges on the sur-
face of MMP-7 (see Fig. 1), although the putative binding
region of neutral liposomes is not clearly apparent.
Since the negative charges appeared to be clustered in the
vicinity of the active site pocket of MMP-7 (see Fig. 1), it
was logical to expect that the enzyme activity would be im-
paired upon binding of MMP-7 to the positively (but not neg-
atively) charged liposomes. To ascertain this, we determinedLipid  (μM)
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Fig. 3. Eﬀect of diﬀerently charged liposomes on MMP-7 activity. The
enzyme-catalyzed hydrolysis of the ﬂuorogenic peptide (kex = 335 nm,
kem = 395 nm) was measured as a function of the liposome concentra-
tions. The symbols s–s, n–n, and h–h represent data obtained in
the presence of anionic, neutral, and cationic liposomes, respectively.
[MMP-7] = 1lM, [Substrate] = 10 lM. Note that unlike anionic and
neutral liposomes, the activity of MMP-7 decreases as a function of
increasing concentrations of cationic liposomes. The solid smooth line
is the best ﬁt of the data (as described by Banerjee et al. [17]) for the Ki
value of MMP-7–cationic liposome complex as being equal to 10 lM.the activity of MMP-7 in the presence of increasing concentra-
tions of diﬀerently charged liposomes (Fig. 3). As expected, the
data (Fig. 3) clearly shows that whereas neutral and negatively
charged liposomes do not inhibit the MMP-7 catalyzed reac-
tion, the positively charged liposomes exhibit a pronounced
inhibitory eﬀect. The analysis of the inhibition data yielded a
Ki value of 10 ± 2 lM for the positively charged (EPOPC-con-
taining) liposomes, which emerged out to be comparable to
their direct binding aﬃnity (Kd = 5 ± 0.9 lM; Table 1). It
should be pointed out that the above similarity leads to the
suggestion that the inhibition of MMP-7 by cationic liposomes
is due to their interaction. However, to exclude the possibility
that the above inhibition is not due to binding of substrates to
the cationic liposomes (such that the substrates are not avail-
able to the enzyme), we performed an analytical HPLC (using
a C18 reverse phase column) experiment. In this experiment, we
compared the elution proﬁles of the substrate (10 lM) in the
absence and presence of cationic liposomes (200 lM) under
the condition where about 90% MMP-7 was inhibited (see
Fig. 3). The experimental data revealed that the elution time
of the substrate remained unchanged in the presence of cat-
ionic liposomes, suggesting that the substrate did not interact
with the liposomes (see ESI Fig. S3). In the light of these data,
it appears plausible that the coulombic interaction between the
negatively charged active site surface of MMP-7 and the
cationic phospholipid head groups of the liposomes blocks
the accessibility of substrate (to the active site pocket of the
enzyme), causing the inhibition of the enzyme. Since the nega-
tively charged liposomes are unlikely to block the accessibility
of the enzyme’s active site pocket for its substrate (due to po-
tential coulombic repulsion), they do not exhibit the inhibitory
eﬀect. The site speciﬁc binding of anionic versus cationic
liposomes is also apparent from the diﬀerence in ﬂuorescence
emission proﬁles of the MMP-7-liposome complexes (compare
Fig. 2 and ESI-Fig. S1).
In summary, we report herein, for the ﬁrst time, that
MMP-7 not only interacts with anionic lipid membranes,
but it also interacts with cationic and neutral lipid mem-
branes. When bound to the negatively charged or neutral
membranes, the active site pocket of the enzyme remains
unobstructed and the enzyme stays fully active. In contrast,
when MMP-7 binds to the positively charged membranes, it
is drastically inhibited, and this is presumably due to the ori-
entation of the enzyme’s active site pocket toward the posi-
tively charged membrane surface. We surmise that in the
physiological milieu, the catalytic activity of MMP-7 could
be ﬁne-tuned by selective interaction with membranes of dif-
ferent charge and/or membrane-resident proteins, and the
outcome of these studies will lead to the development of ther-
apeutic/diagnostic tools for MMP-7, which is known to be
over-expressed in a variety of pathological conditions, includ-
ing cancers [13].Acknowledgements: This work was supported by NIH and NSF Grants
CA113746 and DMR-0705767, respectively, to D.K.S. and S.M.Appendix A. Supplementary material
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2007.11.
042.
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